Romain M. Wolf

Novartis (Switzerland) — Switzerland

Biochemistry, Genetics and Molecular Biology · Life Sciences

29h-index22.7kcitations77works2.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

DNA and Nucleic Acid Chemistry(34), RNA and protein synthesis mechanisms(19), Advanced biosensing and bioanalysis techniques(14), Chemical Synthesis and Analysis(12), Analytical Chemistry and Chromatography(7)

Publications77 total

Discovery of GJG057, a Potent and Highly Selective Inhibitor of Leukotriene C4 Synthase
Journal of Medicinal Chemistry·2025· 2 cited
Discovery of Amino Alcohols as Highly Potent, Selective, and Orally Efficacious Inhibitors of Leukotriene A4 Hydrolase
Journal of Medicinal Chemistry·2023· 6 citedOpen Access
Photothermal activation in the near infrared range for 4-dimensional printing using relevant organic dyes
Additive manufacturing·2022· 18 citedOpen Access
Comparison of pure epoxy vs. epoxy-anhydride photopolymerization
European Polymer Journal·2022· 7 cited
Photothermal Activation in the Near Infrared Range for 4-Dimensional Printing Using Near Infrared Organic Dyes
SSRN Electronic Journal·2022Open Access
Amber 2021: Reference Manual
Open Repository and Bibliography (University of Luxembourg)·2021· 171 cited
Discovery of LYS006, a Potent and Highly Selective Inhibitor of Leukotriene A<sub>4</sub> Hydrolase
Journal of Medicinal Chemistry·2021· 29 citedOpen Access
Ultrafast Epoxy‐Anhydride Photopolyaddition Reaction
Macromolecular Chemistry and Physics·2020· 5 cited
Optimizing a Weakly Binding Fragment into a Potent RORγt Inverse Agonist with Efficacy in an in Vivo Inflammation Model
Journal of Medicinal Chemistry·2018· 26 citedOpen Access
Feasibility and physiological relevance of designing highly potent aminopeptidase-sparing leukotriene A4 hydrolase inhibitors
Scientific Reports·2017· 33 citedOpen Access
Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors
ACS Medicinal Chemistry Letters·2017· 111 citedOpen Access
Discovery of novel pyrrolidineoxy-substituted heteroaromatics as potent and selective PI3K delta inhibitors with improved physicochemical properties
Bioorganic & Medicinal Chemistry Letters·2016· 20 citedOpen Access
Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective Inhibitors
ACS Medicinal Chemistry Letters·2016· 65 citedOpen Access
Extracting ligands from receptors by reversed targeted molecular dynamics
Journal of Computer-Aided Molecular Design·2015· 3 cited
Reactions to Shocks and Monetary Policy Regimes: Inflation Targeting versus Flexible Currency Board in Ghana, South Africa and the WAEMU
SSRN Electronic Journal·2013· 2 citedOpen Access
MM/GBSA Binding Energy Prediction on the PDBbind Data Set: Successes, Failures, and Directions for Further Improvement
Journal of Chemical Information and Modeling·2012· 311 cited
Molecular Characterization of Oxysterol Binding to the Epstein-Barr Virus-induced Gene 2 (GPR183)
Journal of Biological Chemistry·2012· 48 citedOpen Access
AMBER "Lite": Some AMBER-Tools-Based Utilities
2011
1-Alkyl-4-phenyl-6-alkoxy-1<i>H</i>-quinazolin-2-ones: A Novel Series of Potent Calcium-Sensing Receptor Antagonists
Journal of Medicinal Chemistry·2010· 42 citedOpen Access
Improved model building and assessment of the Calcium‐sensing receptor transmembrane domain
Proteins Structure Function and Bioinformatics·2007· 28 cited
page 1 of 4Next →

Frequent Co-authors

Alain De Mesmaeker(16), Valérie Fritsch(12), Adrian Waldner(10), Jacques Lebreton(10), Eric Francotte(6), Susan M. Freier(5), Sebastian Wendeborn(5), Klaus Seuwen(4), Klemens Hoegenauer(4), Junmei Wang(3), Peter A. Kollman(3), David A. Case(3), Pier Luigi Luisi(3), Nicolas Soldermann(3), Frédéric J. Zécri(3), Alexander B. Smith(3), Gregory J. Hollingworth(3), Christoph Burkhart(3), Janet Dawson(3), Chantal Jouanno(3)